Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4394259
  • Report
  • 143 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Adaltis S.r.l.
  • Biokit SA
  • Da An Gene Co Ltd
  • GeneProof AS
  • Hologic Inc
  • OPKO Health Inc
  • MORE
Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Herpes Simplex Virus Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Herpes Simplex Virus Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Herpes Simplex Virus Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Herpes Simplex Virus Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Herpes Simplex Virus Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adaltis S.r.l.
  • Biokit SA
  • Da An Gene Co Ltd
  • GeneProof AS
  • Hologic Inc
  • OPKO Health Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Herpes Simplex Virus Diagnostic Tests Overview
3 Products under Development
3.1 Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Territory
3.3 Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date
4 Herpes Simplex Virus Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Herpes Simplex Virus Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Stage of Development
5 Herpes Simplex Virus Diagnostic Tests Companies and Product Overview
5.1 Adaltis S.r.l. Company Overview
5.1.1 Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Becton Dickinson and Co Company Overview
5.2.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.3 Biokit SA Company Overview
5.3.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cepheid Company Overview
5.4.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.5 Da An Gene Co Ltd Company Overview
5.5.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 DiaSorin S.p.A Company Overview
5.6.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
5.7 GeneProof AS Company Overview
5.7.1 GeneProof AS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Genera Biosystems Ltd Company Overview
5.8.1 Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Hologic Inc Company Overview
5.9.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Infopia Co Ltd Company Overview
5.10.1 Infopia Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 OPKO Health Inc Company Overview
5.11.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Paramedical Srl Company Overview
5.12.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
5.13 Qiagen NV Company Overview
5.13.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.14 Roche Diagnostics International Ltd Company Overview
5.14.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sansure Biotech Inc Company Overview
5.15.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthcare GmbH Company Overview
5.16.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.17 Theranos Inc Company Overview
5.17.1 Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of Texas Medical Branch at Galveston Company Overview
5.18.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.19 VEGA Ltd Company Overview
5.19.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Herpes Simplex Virus Diagnostic Tests - Recent Developments
6.1 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
6.2 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
6.3 Aug 15, 2017: NIH herpesvirus study in mice leads to discovery of potential broad-spectrum antiviral
6.4 Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results
6.5 Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors
6.6 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results
6.7 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
6.8 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results
6.9 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017
6.10 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017
6.11 Aug 01, 2017: Theranos Reaches Settlement with Walgreens
6.12 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
6.13 Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results
6.14 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results
6.15 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results
6.16 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017
6.17 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China
6.18 Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement
6.19 Jun 20, 2017: Hologic Announces FDA Clearance of Aptima Assay to Detect Herpes Simplex Virus 1 & 2
6.20 Jun 06, 2017: BD Releases 2016 Sustainability Report
6.21 May 17, 2017: Theranos Names Former Abbott Diagnostics Executive Cass Grandone as Head of Product Development
6.22 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors
6.23 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017
6.24 May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire
6.25 May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results
6.26 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results
6.27 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
6.28 May 02, 2017: QIAGEN reports results for first quarter 2017
6.29 May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance
6.30 May 01, 2017: Theranos Reaches Settlement with Partner Fund Management
6.31 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017
6.32 Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results
6.33 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results
6.34 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
6.35 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results
6.36 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
6.37 Mar 21, 2017: Retractable Technologies Announces Litigation Updates
6.38 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results
6.39 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors
6.40 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
6.41 Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
6.42 Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results
6.43 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.44 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.45 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
6.46 Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results
6.47 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter
6.48 Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016
6.49 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017
6.50 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories
6.51 Jan 17, 2017: Theranos Announces Engineering Experts Join Company’s New Technology Advisory Board
6.52 Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance
6.53 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016
6.54 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
6.55 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index
6.56 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors
6.57 Dec 12, 2016: Theranos Enhances Executive Ranks
6.58 Dec 01, 2016: Theranos appoints new board member
6.59 Nov 29, 2016: Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus
6.60 Nov 15, 2016: Hologic Obtains European CE Mark for Aptima Assay to Detect Herpes Simplex Virus 1 & 2
6.61 Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results
6.62 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016
6.63 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results
6.64 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
6.65 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
6.66 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
6.67 Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017
6.68 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
6.69 Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance
6.70 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results
6.71 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results
6.72 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
6.73 Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance
6.74 Oct 05, 2016: An Open Letter From Elizabeth Holmes
6.75 Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard
6.76 Oct 03, 2016: Genera Biosystems: 2016 Annual Report Highlights
6.77 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Territory
Table 3: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Herpes Simplex Virus Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 6: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Stage of Development
Table 7: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 8: MOLgen DNA HSV - 1,2 Set 1 Kit - Product Status
Table 9: MOLgen DNA HSV - 1,2 Set 1 Kit - Product Description
Table 10: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 11: BD Viper LT HSV 1/2 Assay - Product Status
Table 12: BD Viper LT HSV 1/2 Assay - Product Description
Table 13: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 14: BIO-FLASH HSV 1+2 IgM Assay - Product Status
Table 15: BIO-FLASH HSV 1+2 IgM Assay - Product Description
Table 16: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Xpert HSV 1 And 2 Test - Product Status
Table 18: Xpert HSV 1 And 2 Test - Product Description
Table 19: Xpert HSV CSF Assay - Product Status
Table 20: Xpert HSV CSF Assay - Product Description
Table 21: Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Real Time PCR Kit - HSV General Type - Product Status
Table 23: Real Time PCR Kit - HSV General Type - Product Description
Table 24: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Assay - HSV M + cntr - Product Status
Table 26: Diagnostic Assay - HSV M + cntr - Product Description
Table 27: GeneProof AS Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Human Herpes Virus 6/7 PCR Kit - Product Status
Table 29: Human Herpes Virus 6/7 PCR Kit - Product Description
Table 30: Human Herpes Virus 8 PCR Kit - Product Status
Table 31: Human Herpes Virus 8 PCR Kit - Product Description
Table 32: Genera Biosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Status
Table 34: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Description
Table 35: Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Panther Fusion - HSV 1 & 2 Assay - Product Status
Table 37: Panther Fusion - HSV 1 & 2 Assay - Product Description
Table 38: Panther System - HSV-2 Assay - Product Status
Table 39: Panther System - HSV-2 Assay - Product Description
Table 40: Infopia Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: GeneFinder STDIII (HSV1/2/UP) Real Amp Kit - Product Status
Table 42: GeneFinder STDIII (HSV1/2/UP) Real Amp Kit - Product Description
Table 43: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: mChip - Herpes - Product Status
Table 45: mChip - Herpes - Product Description
Table 46: Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 47: PKL PPC - Torch - ANTI HSV1 IGG - Product Status
Table 48: PKL PPC - Torch - ANTI HSV1 IGG - Product Description
Table 49: PKL PPC - Torch - ANTI HSV1 IGM - Product Status
Table 50: PKL PPC - Torch - ANTI HSV1 IGM - Product Description
Table 51: PKL PPC - Torch - ANTI HSV1+2 IGM - Product Status
Table 52: PKL PPC - Torch - ANTI HSV1+2 IGM - Product Description
Table 53: PKL PPC - Torch - ANTI HSV2 IGG - Product Status
Table 54: PKL PPC - Torch - ANTI HSV2 IGG - Product Description
Table 55: PKL PPC - Torch - ANTI HSV2 IGM - Product Status
Table 56: PKL PPC - Torch - ANTI HSV2 IGM - Product Description
Table 57: Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
Table 58: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Status
Table 59: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Description
Table 60: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Status
Table 62: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Description
Table 63: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Status
Table 64: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Description
Table 65: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Status
Table 66: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Description
Table 67: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Status
Table 68: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Description
Table 69: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Herpes Simplex Virus (1/2) DNA Fluorescence Diagnostic Kit - Product Status
Table 71: Herpes Simplex Virus (1/2) DNA Fluorescence Diagnostic Kit - Product Description
Table 72: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 73: ADVIA Centaur CP Immunoassay System - Herpes I Assay - Product Status
Table 74: ADVIA Centaur CP Immunoassay System - Herpes I Assay - Product Description
Table 75: ADVIA Centaur CP Immunoassay System - Herpes II Assay - Product Status
Table 76: ADVIA Centaur CP Immunoassay System - Herpes II Assay - Product Description
Table 77: ADVIA Centaur XP Immunoassay System - Herpes I Assay - Product Status
Table 78: ADVIA Centaur XP Immunoassay System - Herpes I Assay - Product Description
Table 79: ADVIA Centaur XP Immunoassay System - Herpes II Assay - Product Status
Table 80: ADVIA Centaur XP Immunoassay System - Herpes II Assay - Product Description
Table 81: Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: HSV-1 IgG Test - Venous/Capillary - Product Status
Table 83: HSV-1 IgG Test - Venous/Capillary - Product Description
Table 84: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Diagnostic Assay - HSV - Product Status
Table 86: Diagnostic Assay - HSV - Product Description
Table 87: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Enzyme Immunoassay - HSV2 - Product Status
Table 89: Enzyme Immunoassay - HSV2 - Product Description
Table 90: Glossary

List of Figures
Figure 1: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Territory
Figure 3: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Herpes Simplex Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Adaltis S.r.l.
  • Becton Dickinson and Co
  • Biokit SA
  • Cepheid
  • Da An Gene Co Ltd
  • DiaSorin S.p.A
  • GeneProof AS
  • Genera Biosystems Ltd
  • Hologic Inc
  • Infopia Co Ltd
  • OPKO Health Inc
  • Paramedical Srl
  • Qiagen NV
  • Roche Diagnostics International Ltd
  • Sansure Biotech Inc
  • Siemens Healthcare GmbH
  • Theranos Inc
  • University of Texas Medical Branch at Galveston
  • VEGA Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll